These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22996185)

  • 21. Natural history of cardiovascular and renal disease in patients with type 2 diabetes: effect of therapeutic interventions and risk modification.
    Mogensen CE
    Am J Cardiol; 1998 Nov; 82(9B):4R-8R. PubMed ID: 9822136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Davies MJ; D'Alessio DA; Fradkin J; Kernan WN; Mathieu C; Mingrone G; Rossing P; Tsapas A; Wexler DJ; Buse JB
    Diabetologia; 2018 Dec; 61(12):2461-2498. PubMed ID: 30288571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2 diabetes and cardiovascular risk factors.
    Sharma MD; Farmer JA; Garber A
    Curr Med Res Opin; 2011 Nov; 27 Suppl 3():1-5. PubMed ID: 22106974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case presentations--challenging problems in the management of type 2 diabetes.
    Scott AR; Donnelly R
    Diabetes Obes Metab; 2000 Mar; 2 Suppl 1():S49-55. PubMed ID: 11225760
    [No Abstract]   [Full Text] [Related]  

  • 25. Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum.
    Raz I; Riddle MC; Rosenstock J; Buse JB; Inzucchi SE; Home PD; Del Prato S; Ferrannini E; Chan JC; Leiter LA; Leroith D; Defronzo R; Cefalu WT
    Diabetes Care; 2013 Jun; 36(6):1779-88. PubMed ID: 23704680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [How effectively should hyperglycemia be treated in a type 2 diabetes patient?].
    Eriksson J
    Duodecim; 2009; 125(13):1387-94. PubMed ID: 19678494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
    Inzucchi SE; Bergenstal RM; Buse JB; Diamant M; Ferrannini E; Nauck M; Peters AL; Tsapas A; Wender R; Matthews DR
    Diabetes Care; 2015 Jan; 38(1):140-9. PubMed ID: 25538310
    [No Abstract]   [Full Text] [Related]  

  • 28. The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Holt RIG; DeVries JH; Hess-Fischl A; Hirsch IB; Kirkman MS; Klupa T; Ludwig B; Nørgaard K; Pettus J; Renard E; Skyler JS; Snoek FJ; Weinstock RS; Peters AL
    Diabetes Care; 2021 Nov; 44(11):2589-2625. PubMed ID: 34593612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis.
    Schernthaner G; Barnett AH; Betteridge DJ; Carmena R; Ceriello A; Charbonnel B; Hanefeld M; Lehmann R; Malecki MT; Nesto R; Pirags V; Scheen A; Seufert J; Sjohölm A; Tsatsoulis A; DeFronzo R
    Diabetologia; 2010 Jul; 53(7):1258-69. PubMed ID: 20352408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes care in the school setting: a position statement of the American Diabetes Association.
    Jackson CC; Albanese-O'Neill A; Butler KL; Chiang JL; Deeb LC; Hathaway K; Kraus E; Weissberg-Benchell J; Yatvin AL; Siminerio LM
    Diabetes Care; 2015 Oct; 38(10):1958-63. PubMed ID: 26404925
    [No Abstract]   [Full Text] [Related]  

  • 31. Comment on Inzucchi et al. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease. Diabetes Care 2016;39:1684-1692.
    Katsiki N; Mikhailidis DP
    Diabetes Care; 2017 Apr; 40(4):e46. PubMed ID: 28325803
    [No Abstract]   [Full Text] [Related]  

  • 32. [Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes].
    Shimizu T; Nathan DM; Buse JB; Davidson MB; Ferrannini E; Holman RR; Sherwin R; Zinman B
    Nihon Rinsho; 2012 May; 70 Suppl 3():591-601. PubMed ID: 22768584
    [No Abstract]   [Full Text] [Related]  

  • 33. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: response to Skyler et al.
    Lund SS; Vaag AA
    Diabetes Care; 2009 Jul; 32(7):e90-1; author reply e92-3. PubMed ID: 19564469
    [No Abstract]   [Full Text] [Related]  

  • 34. Response to Comment on Inzucchi et al. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease. Diabetes Care 2016;39:1684-1692.
    Inzucchi SE; Viscoli CM; Young LH; Furie KL; Gorman M; Lovejoy AM; Dagogo-Jack S; Ismail-Beigi F; Korytkowski MT; Pratley RE; Schwartz GG; Kernan WN;
    Diabetes Care; 2017 Apr; 40(4):e47-e48. PubMed ID: 28325804
    [No Abstract]   [Full Text] [Related]  

  • 35. Dysglycaemia, cardiovascular outcome and treatment. Is the jury still out?
    Bartnik M; Cosentino F
    Eur Heart J; 2009 Jun; 30(11):1301-4. PubMed ID: 19395498
    [No Abstract]   [Full Text] [Related]  

  • 36. Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711-1721.
    Cerasi E
    Diabetologia; 2007 Mar; 50(3):693-4. PubMed ID: 17187245
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic balance. What is left to internal medicine?].
    Koeppe HW
    Ther Ggw; 1970 May; 109(5):662 passim. PubMed ID: 5422182
    [No Abstract]   [Full Text] [Related]  

  • 38. Beyond the UKPDS: in search of the optimal strategy for the treatment of type 2 diabetes.
    Riccardi G
    Nutr Metab Cardiovasc Dis; 2000 Jun; 10(3):104-7. PubMed ID: 11006917
    [No Abstract]   [Full Text] [Related]  

  • 39. Erratum. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2020;43:487-493.
    Buse JB; Wexler DJ; Tsapas A; Rossing P; Mingrone G; Mathieu C; D'Alessio DA; Davies MJ
    Diabetes Care; 2020 Jul; 43(7):1670. PubMed ID: 32444453
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current trends in diet therapy].
    Abe T
    Iryo; 1967 Jun; 21(6):647-55. PubMed ID: 6079024
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.